Liver Metastases Treatment Market Trends

• With cancer cases on the rise globally, particularly in organs prone to metastatic spread like the lungs, breast, and colon, liver metastases have become increasingly prevalent.
  
• For instance, according to the WHO, colorectal cancer is the third most common cancer worldwide, accounting for approximately 10% of all cancer cases. Similarly, as per the World Cancer Research Fund International, there were more than 1.9 million new cases of colorectal cancer in 2020.
  
• Further, the Memorial Sloan Kettering Cancer Center stats that up to 70 percent of people with colorectal cancer eventually develop liver metastases.
  
• Thus, with increasing number of cancer diagnosis coupled with high potential of liver metastasis, the demand for effective treatment options has soared, thereby propelling the market growth.
  
• Moreover, collaborative efforts between healthcare providers and regulatory authorities are aimed at streamlining treatment protocols and ensuring broader accessibility to novel therapies, thus fueling the market growth.